Amarna Therapeutics announces appointment of Dr Henk Streefkerk as new CEO
LEIDEN, Netherlands, June 7, 2023 /PRNewswire/ — Amarna Therapeutics, a privately-held biotechnology company developing transformative gene therapies in a range of rare and prevalent diseases, including Hemophilia B, today announces the appointment of Dr Henk Streefkerk as the Company’s…
Comments Off on Amarna Therapeutics announces appointment of Dr Henk Streefkerk as new CEO